Why the study?
Do clinical risk markers accurately stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
Do clinical risk markers accurately stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
This systematic review confirms the validity of the six major clinical risk markers for predicting sudden cardiac death in hypertrophic cardiomyopathy and suggests adding left ventricular outflow tract obstruction to the risk profile.
No takes yet. Share an insight, caveat, or question.
Affirms six major SCD risk factors plus LVOTO association in HCM; confirms established markers and extends stratification models.
Christiaans et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: